EUVIMEDEUVIMED entdecken
Open Access

Reduction of Cerebrospinal Fluid Leaks in Idiopathic Intracranial Hypertension with Glucagon-like Peptide-1 Receptor Agonist Use

Adam S Vesole iD, Steven A Gordon, Ahmad R Sedaghat, Katie M Phillips, Jonathan Forbes, Norberto Andaluz, Daniel Q Sun

Journal of Neurological Surgery Part B: Skull Base · 01.08.2026 · 87 (04) · 490-494

DOI: 10.1055/a-2678-8331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.08.2026. Verfasst von Adam S Vesole und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elevated intracranial pressure (ICP) secondary to idiopathic intracranial hypertension (IIH) is a recognized risk factor for anterior and lateral skull base cerebrospinal fluid (CSF) leaks. A recent randomized controlled trial (Mitchell et al) demonstrated a significant reduction of ICP in IIH with the use glucagon-like peptide-1 (GLP-1) receptor agonists. This retrospective population study aims to evaluate the role of GLP-1 agonists in reducing CSF leaks. Retrospective cohort database study. A collaborative global database (TriNetX) sourced from electronic medical records from 99 large healthcare organizations across the world. Adults (≥18 years old) with a diagnosis of IIH, stratified into groups based on the presence or absence of concurrent GLP-1 agonist use. The rate of spontaneous cranial CSF leak and the rate of anterior/lateral skull base CSF leak repair between GLP-1 users versus non-users over 3 years. Compared with IIH patients not taking GLP-1 agonists (n = 11,825), IIH patients on GLP-1 agonists (n = 11,825) were 24% less likely to develop a spontaneous cranial CSF leak (OR 0.76, 95% CI, 0.61–0.94) and 72% less likely to undergo skull base CSF leak repair (OR 0.28, 95% CI, 0.15–0.51). GLP-1 agonist use in IIH patients is associated with a lower incidence of spontaneous cranial CSF leaks and a decreased rate of undergoing anterior and/or lateral skull base CSF leak repairs. These promising findings suggest that GLP-1 agonists may be an effective adjuvant therapeutic agent in preventing recurrence following CSF leak repair in IIH patients.

Schlagwörter

Stichwörter der Autor:innen

CSF leakCSF leak repairGLP-1 agonistanterior skull baseidiopathic intracranial hypertensionlateral skull base

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States.
  • Department of Neurosurgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States.

ORCID-Profile: Adam S Vesole

Zitieren

APA

Vesole, A. S., Gordon, S. A., Sedaghat, A. R., Phillips, K. M., Forbes, J., Andaluz, N., & Sun, D. Q. (2026). Reduction of Cerebrospinal Fluid Leaks in Idiopathic Intracranial Hypertension with Glucagon-like Peptide-1 Receptor Agonist Use. Journal of Neurological Surgery Part B: Skull Base, 87(04), 490-494. https://doi.org/10.1055/a-2678-8331

Vancouver

Vesole AS, Gordon SA, Sedaghat AR, Phillips KM, Forbes J, Andaluz N, et al. Reduction of Cerebrospinal Fluid Leaks in Idiopathic Intracranial Hypertension with Glucagon-like Peptide-1 Receptor Agonist Use. Journal of Neurological Surgery Part B: Skull Base. 2026;87(04):490-494. doi:10.1055/a-2678-8331

BibTeX
@article{Vesole2026,
  author = {Vesole, Adam S and Gordon, Steven A and Sedaghat, Ahmad R and Phillips, Katie M and Forbes, Jonathan and Andaluz, Norberto and Sun, Daniel Q},
  title = {Reduction of Cerebrospinal Fluid Leaks in Idiopathic Intracranial Hypertension with Glucagon-like Peptide-1 Receptor Agonist Use},
  journal = {Journal of Neurological Surgery Part B: Skull Base},
  year = {2026},
  volume = {87},
  number = {04},
  pages = {490--494},
  doi = {10.1055/a-2678-8331}
}
Kostenlos starten →